US Patent 7202247 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
Patent 7202247 was granted and assigned to Atherogenics on April, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+132 characters)
Article
Patent abstract
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07202247 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders US Patent 7202247 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
Infobox
Patent Number
0720224700
Patent Number
720224700
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072022470
Date of Patent
April 10, 2007
0Patent Application Number
103250870
Date Filed
December 19, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072022470
Date of Patent
April 10, 2007
0Patent Application Number
103250870
Date Filed
December 19, 2002
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07202247 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07202247
Date of patent
April 10, 2007
Patent application number
10325087
Date Filed
December 19, 2002
Patent primary examiner
Find more entities like US Patent 7202247 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
